Context-dependent multifunctionality of galectin-1: a challenge for defining the lectin as therapeutic target
Introduction: One route of translating the information encoded in the glycan chains of cellular glycoconjugates into physiological effects is via receptor (lectin) binding. A family of endogenous lectins, sharing folding, a distinct sequence signature and affinity for β-galactosides (thus termed gal...
Saved in:
| Main Authors: | , , , , |
|---|---|
| Format: | Article (Journal) |
| Language: | English |
| Published: |
2013
|
| In: |
Expert opinion on therapeutic targets
Year: 2013, Volume: 17, Issue: 4, Pages: 379-392 |
| ISSN: | 1744-7631 |
| DOI: | 10.1517/14728222.2013.750651 |
| Online Access: | Verlag, lizenzpflichtig, Volltext: https://doi.org/10.1517/14728222.2013.750651 Verlag, lizenzpflichtig, Volltext: https://www.tandfonline.com/doi/full/10.1517/14728222.2013.750651 
|
| Author Notes: | Karel Smetana, Sabine André, Herbert Kaltner, Jürgen Kopitz & Hans-Joachim Gabius |
| Summary: | Introduction: One route of translating the information encoded in the glycan chains of cellular glycoconjugates into physiological effects is via receptor (lectin) binding. A family of endogenous lectins, sharing folding, a distinct sequence signature and affinity for β-galactosides (thus termed galectins), does so effectively in a context-dependent manner. Areas covered: An overview is given on the multifunctional nature of galectins, with emphasis on galectin-1. The broad range of functions includes vital processes such as adhesion via glycan bridging, glycoconjugate transport or triggering signaling relevant, for example, for growth regulation. Besides distinct glycoconjugates, this lectin can also interact with certain proteins so that it can target counterreceptors at all sites of location, that is, in the cytoplasm and/or nucleus, at both sides of the membrane or extracellularly. Approaches to strategically exploit galectin activities with therapeutic intentions are outlined. Expert opinion: The wide versatility of sugar coding and the multifunctionality of galectin-1 explain why considering to turn the protein into a therapeutic target is an ambitious aim. Natural pathways shaped by physiologic master regulators (e.g., the tumor suppressor p16INK4a) are suggested to teach inspiring lessons as to how the lectin might be recruited to clinical service. |
|---|---|
| Item Description: | Published online: 06 Jan 2013 Gesehen am 07.02.2022 |
| Physical Description: | Online Resource |
| ISSN: | 1744-7631 |
| DOI: | 10.1517/14728222.2013.750651 |